Treatment of specific macrovascular beds in patients with diabetes mellitus

Osteopathic Medicine and Primary Care

Volumn 4, Issue , 2010, Pages

  Petznick, Allison M ^a   Shubrook, Jay H ^a  

^a OHIO UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 77955346623     PISSN: None     EISSN: 17504732     Source Type: Journal    
DOI: 10.1186/1750-4732-4-5     Document Type: Review

References (36)

1. National Health and Nutrition Examination Survey III Electronic References Retrieved December 30, 2009, National Health and Nutrition Examination Survey III., http://apps.nccd.cdc.gov/DDTSTRS/FactSheet.aspx
2. Lankisch M, Futh R, Gulker H, Lapp H, Bufe A, Haastert B, Martin S, Rathmann W. Screening for undiagnosed diabetes in patients with acute myocardial infarction. Clinical Research in Cardiology 2008, 97:753-759. 10.1007/s00392-008-0674-5, 18491170.
3. Fradkin J, Rodgers GP. The Economic Imperative to Conquer Diabetes. Diabetes Care 2008, 31:624-625. 10.2337/dc08-0088, 18308686.
4. Multiple Risk Factor Intervention Trial Research Group Multiple Risk Factor Intervention Trial: Risk Factor Changes and Mortality Results. JAMA 1982, 248:1465-1477. 10.1001/jama.248.12.1465, 7050440, Multiple Risk Factor Intervention Trial Research Group.
5. Huang ES, Meigs JB, Singer DE. The Effect of Interventions to Prevent Cardiovascular Disease in Patients with Type 2 Diabetes Mellitus. The American Journal of Medicine 2001, 111:633-642. 10.1016/S0002-9343(01)00978-0, 11755507.
6. American Diabetes Association Standards of Medical Care in Diabetes-2010. Diabetes Care 2010, 33:S11-S61. 10.2337/dc10-S011, 20042772, American Diabetes Association.
7. UK Prospective Diabetes Study Group Intensive Blood Glucose Control with Sulphonylureas or Insulin Compared with Conventional Treatment and Risk of Complications in Patients with Type 2 Diabetes. Lancet 1998, 352:837-853. 10.1016/S0140-6736(98)07019-6, 9742976, UK Prospective Diabetes Study Group.
8. Stratton IM, Adler AI, Neil HA, Matthews DR, Manley SE, Cull CA, Hadden D, Turner RC, Holman RR. Association of glycemia with Macrovascular and Microvascular Complications of Type 2 diabetes (UKPDS 35): Prospective Observational Study. British Medical Journal 2000, 321:405-412. 10.1136/bmj.321.7258.405, 27454, 10938048.
9. The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study Research Group Intensive Diabetes Treatment and Cardiovascular Disease in Patients with Type 1 Diabetes. The New England Journal of Medicine 2005, 353:2643-2653. 10.1056/NEJMoa052187, 2637991, 16371630, The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study Research Group.
10. Haffner SM. Obesity and the Metabolic Syndrome: The San Antonio Heart Study. British Journal of Nutrition 2000, 83:S67-S70. 10.1017/S0007114500000970, 10889794.
11. Dokken BB. The Pathophysiology of Cardiovascular Disease and Diabetes: Beyond Blood Pressure and Lipids. Diabetes Spectrum 2008, 21:160-165. also reference 36.
12. Roelker E. Screening for Coronary Artery Disease in Patients with Diabetes. Diabetes Spectrum 2008, 21:166-171.
13. Fasy EA. Assessing Cardiovascular Risk in Asymptomatic Diabetes: The DIAD Study. Diabetes Care 2004, 27:1954-1961. 10.2337/diacare.27.8.1954, 15277423.
14. Ali YS, Maron DJ. Screening for Coronary Disease in Diabetes: When and How. Clinical Diabetes 2006, 24:169-173.
15. Gibbons RJ, Abrams J, Chatterjee K, Daley J, Deedwania PC, Douglas JS, Ferguson TB, Fihn SD, Fraker TD, Gardin JM, O'Rourke RA, Pasternak RC, Williams SV, Alpert JS, Antman EM, Hiratzka LF, Fuster V, Faxon DP, Gregoratos G, Jacobs AK, Smith SC. ACC/AHA 2002 Guideline Update for the Management of Patients With Chronic Stable Angina.
16. Boden WE, O'Rourke RA, Teo KK, Hartigan PM, Maron DJ, Kostuk WJ. The COURAGE Trial Research Group. Optimal Medical Therapy With or Without PCI for Stable Coronary Disease. The New England Journal of Medicine 2007, 356:1503-1516. 10.1056/NEJMoa070829, 17387127.
17. The BARI Investigators The Final 10 Year Follow-Up Results From the BARI Randomized Trial. Journal of the American College of Cardiology 2007, 49:1600-1606. 10.1016/j.jacc.2006.11.048, 17433949, The BARI Investigators.
18. The BARI 2D Study Group A Randomized Trial of Therapies for Type 2 Diabetes and Coronary Artery Disease. The New England Journal of Medicine 2009, 360:2503-2515. 10.1056/NEJMoa0805796, 2863990, 19502645, The BARI 2D Study Group.
19. Steffen LM, Duprez DA, Boucher JL, Ershow AG, Hirsch AT. Management of Peripheral Arterial Disease. Diabetes Spectrum 2008, 21:171-177.
20. American Diabetes Association Peripheral Arterial Disease in People with Diabetes. Diabetes Care 2003, 26:3333-3341. 10.2337/diacare.26.12.3333, 14633825, American Diabetes Association.
21. Carman TL, Fernandez BB. A Primary Care Approach to the Patient with Claudication. American Family Physician 2000, 61:1027-1034.
22. Marso SP, Hiatt WR. Peripheral Arterial Disease in Patients with Diabetes. Journal of the American College of Cardiology 2006, 47:921-929. 10.1016/j.jacc.2005.09.065, 16516072.
23. Jonason T, Bergstrom R. Cessation of Smoking in Patients with Intermittent Claudication. Effects of the Risk of Peripheral Vascular Complications, Myocardial Infarction and Mortality. Acta Med Scandinavica 1987, 221:253-260.
24. CAPRIE Steering Committee A Randomised, Blinded, Trial of Clopidogrel Versus Aspirin in Patients at Risk of Ischemic Events (CAPRIE). The Lancet 1996, 348:1329-1339. CAPRIE Steering Committee.
25. Creasy TS, McMillan PJ, Fletcher EWL, Collin J, Morris PJ. Is Percu-taneous Transluminal Angioplasty Better than Exercise for Claudication? Pre-liminary Results from a Prospective Randomized Trial. European Journal of Vascular Surgery 1990, 4:135-140. 10.1016/S0950-821X(05)80427-X, 2140987.
26. Almahamee A, Bhatt DL. Contemporary Management of Peripheral Arterial Disease: Endovascular and Surgical Management. Cleveland Clinic Journal of Medicine 2006, 73:S45-S51. 10.3949/ccjm.73.Suppl_4.S45, 17385391.
27. Air EL, Kissela BM. Diabetes, the Metabolic Syndrome, and Ischemic Stroke: Epidemiology and Possible Mechanisms. Diabetes Care 2007, 30:3131-3140. 10.2337/dc06-1537, 17848611.
28. Sander D, Sander K, Poppert H. Stroke in Type 2 Diabetes. The British Journal of Diabetes and Vascular Disease 2008, 8:222-229.
29. Dahlof B, Devereux RB, Kjeldsen SE, Julius S, Beevers G, Faire U, Fyhrquist F, Ibsen H, Kristiansson K, Lederballe-Pedersen O, Lindholm LH, Nieminen MS, Omvik P, Oparil S, Wedel H. Cardiovascular Morbidity and Mortality in the Losartan Intervention For Endpoint Reduction in Hypertension Study (LIFE): A Randomized Trial Against Atenolol. Lancet 2002, 359:995-1003. 10.1016/S0140-6736(02)08089-3, 11937178.
30. Schrader J, Luders S, Kulschewski A, Hammersen F, Plate K, Berger J, Zidek W, Dominiak P, Diener HC. Morbidity and Mortality After Stroke, Eprosartan Compared with Nitrendipine for Secondary Prevention: Principal Results of a Prospective Randomized Controlled Study (MOSES). Stroke 2005, 36:1218-1226. 10.1161/01.STR.0000166048.35740.a9, 15879332.
31. The ONTARGET Investigators Telmisartan, Ramipril, or Both in Patients at High Risk for Vascular Events. The New England Journal of Medicine 2008, 358:1547-1559. 10.1056/NEJMoa0801317, 18378520, The ONTARGET Investigators.
32. Colhoun HM, Betteridge DJ, Durrington PN, Hitman GA, Neil AW, Livingstone SJ, Thomason MJ, Mackness MI, Charlton-Menys V, Fuller JH. Primary Prevention of Cardiovascular Disease with Atorvastatin in Type 2 Diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): Multicenter Randomized Placebo-Controlled Trial. Lancet 2004, 364:685-696. 10.1016/S0140-6736(04)16895-5, 15325833.
33. Farmer JA, Gotto AM. The Heart Protection Study: Expanding the Boundaries for High-Risk Coronary Disease Prevention. The American Journal of Cardiology 2003, 92:3-9.
34. Charbonnel B, Dormandy J, Erdmann E, Massi-Benedetti M, Skene A, . PROactive Study Group The Prospective Pioglitazone Clinical Trial in Macrovascular Events (PROactive). Diabetes Care 2004, 27:1647-1653. 10.2337/diacare.27.7.1647, 15220241, PROactive Study Group.
35. Lindsberg PJ, Roine RO. Hyperglycemia in Acute Stroke. Stroke 2004, 35:363-364. 10.1161/01.STR.0000115297.92132.84, 14757880.
36. Gentile NT, Seftchick MW, Huynh T, Kruus LK, Gaughan J. Decreased Mortality by Normalizing Blood Glucose After Acute Ischemic Stroke. Academy of Emergency Medicine 2006, 13:174-180.